Clinical Report: Evaluating Contact Dermatitis Associated with Tissue Adhesives
Overview
This study investigates the incidence of contact dermatitis associated with two tissue adhesives, Dermabond™ and LiquiBand®, in patients undergoing laparoscopic surgery. The randomized controlled trial aims to compare the rates of dermatitis between the two adhesives.
Background
Tissue adhesives are increasingly used for surgical incision closure, offering benefits such as rapid application and improved cosmetic outcomes. However, there is limited data on the adverse effects, particularly contact dermatitis, which can range from minor irritation to significant skin damage.
Data Highlights
No numerical data was provided in the source material.
Key Findings
The reported rate of contact dermatitis associated with tissue adhesive use varies from 0 to 14% in existing literature.
Dermabond™ was the first cyanoacrylate-based adhesive approved by the FDA for external use in 1998.
LiquiBand® is formulated for more rapid polymerization compared to Dermabond™.
No studies have directly compared the rates of contact dermatitis between Dermabond™ and LiquiBand®.
The study is designed as a randomized controlled trial to evaluate the incidence of dermatitis at 6 weeks postoperative.
Clinical Implications
Surgeons should be aware of the potential for contact dermatitis when using tissue adhesives.
Conclusion
This study aims to clarify the incidence of contact dermatitis associated with two commonly used tissue adhesives.
by Julie L. Holihan, Abigail G. Wrather, Claire Lancaster, Kulvinder S. Bajwa, Melissa M. Felinski, Shinil K. Shah, Jonah J. Stulberg, Todd D. Wilson, Erik B. Wilson
